Skip to main contentSkip to navigation
Sirius Investors
Celyad Oncology S.A.

Celyad Oncology S.A.

CYAD
NASDAQHealthcare

CYAD Earnings Reports, EPS & Revenue History

Quarterly EPS and revenue vs. estimates for Celyad Oncology S.A.. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.

EPS and Earnings Announcement

Latest Quarterly EPS
Next Earnings Announcement
Unlock for free

Already registered? Sign in

EPS vs. Estimates

Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.

No chart data available for this range.

EPS & Revenue vs. Estimates

Upgrade
DateEPS ActualEPS Est.EPS Diff.
Mar 24, 2021
0.43-1.17+1.60
Aug 6, 2020
-1.34-1.13-0.21
Mar 25, 2020
-1.08-1.30+0.22
Aug 27, 2019
Mar 29, 2019
Aug 23, 2018
Aug 24, 2016
Aug 24, 2015

Earnings Call Transcripts

Upgrade

Earnings Call Transcripts Require Subscription

Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.

View Pricing Plans

Revenue Breakdown

Want to understand CYAD's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.

View Revenue Breakdown